Back to results
US 2017/0304314 A1Published application
Dosage regiment of ferric maltol
AssigneeIron Therapeutics Holdings AG
InventorsNicholas Mallard, Carl Andrew Sterritt, Julian David Howell
Life of this patent
Estimating the term…
Abstract
The present invention relates to a dosage regimen of ST10 (ferric maltol) for use in the treatment of patients suffering from iron deficiency with or without anaemia. The invention specifically relates to use of ST10 wherein the dose is between 40 mg and 90 mg twice daily.
Claims16
A method of treating or preventing iron deficiency in a subject with or without anaemia, comprising orally administering to the subject a 40 mg to 90 mg dose of ST10 twice daily.
(canceled)
Dependencies are inferred from the claim text.